07 Aug 2025
					
											In-Licensing of Various FDFs needed in France [ENA23716]
																						
											A company focused on the development and manufacturing of a wide range of products is looking for the in-licensing of various FDFs. The supplier must support this enquiry with the EU-CTD dossiers.
1. Desvenlafaxine (50 mg or 100 mg) Tablets
2. Rifamycin 1% Solution for Topical
3. Lidocaine HCL (50mg/ 5 ml) Ampoule
4. Pentamidine (300 mg/ ml) Vial
									1. Desvenlafaxine (50 mg or 100 mg) Tablets
2. Rifamycin 1% Solution for Topical
3. Lidocaine HCL (50mg/ 5 ml) Ampoule
4. Pentamidine (300 mg/ ml) Vial
rd@robustmaterials.com
Hi,
We are a pharmaceutical CRO based at Bangalore, INDIA. If you are looking for OSD and injectable formulation development, please do reach us at rd@robustmaterials.com
											17:08,  09 Aug 2025										
										
										
									 
						
 
				 
			










 
														
